Adam Hacker News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Arix Bioscience PLC: Autolus provides business outlook for 2021 and 2022 DJ Autolus provides business outlook for 2021 and 2022 Arix Bioscience PLC (ARIX) Autolus provides business outlook for 2021 and 2022 06-Jan-2021 / 10:00 GMT/BST Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. Arix Bioscience plc Autolus provides business outlook for 2021 and 2022 LONDON, 06 January 2021: Arix Bioscience plc ("Arix", LSE: ARIX), a global venture capital company...

By BFN News | 07:32 AM | Wednesday 06 January, 2021 Autolus Therapeutics, a portfolio company of healthcare company Syncona, will reduce its headcount by 20% in Q1, which will deliver cost savings of around $15 million, as part of its decision to focus and prioritise the development of the AUTO1 programme. Autolus will seek partnership opportunities to fund additional clinical development plans for AUTO3, in relapsed/refractory diffuse large B cell lymphoma (DLBCL), currently in a Phase 1/2 trial, before progressing the programme into the next phase of development. The company will continue...